Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Up 2,500.0% in October

Integrated BioPharma, Inc. (OTCMKTS:INBP) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 5,200 shares, a growth of 2,500.0% from the October 15th total of 200 shares. Based on an average daily trading volume, of 51,200 shares, the days-to-cover ratio is presently 0.1 days.

Integrated BioPharma Stock Performance

Shares of OTCMKTS:INBP remained flat at $0.33 during trading on Tuesday. Integrated BioPharma has a 52-week low of $0.16 and a 52-week high of $0.35. The stock has a market capitalization of $9.92 million, a price-to-earnings ratio of 33.00 and a beta of 0.62. The company’s 50-day moving average is $0.25 and its two-hundred day moving average is $0.22.

Integrated BioPharma (OTCMKTS:INBP) last issued its quarterly earnings data on Friday, September 20th. The company reported $0.01 EPS for the quarter. The firm had revenue of $12.75 million for the quarter. Integrated BioPharma had a return on equity of 0.59% and a net margin of 0.22%.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.